GlassScriptPhysician profile
Muhammad H Iqbal
NPI 1356547491
$9,485.78
in general payments reported to CMS, 2019-2025
40 companies · $1,906 in 2025
The $1,906 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,633 · 2020: $650 · 2021: $1,019 · 2022: $1,355 · 2023: $1,423 · 2024: $1,499 · 2025: $1,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,728 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,728.34 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,992.32 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,638.51 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,447.20 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Grifols USA, LLC | $540.07 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $373.75 | 2019-2024 | Dupixent |
| Genzyme Corporation | $358.19 | 2019-2025 | |
| Harmony Biosciences LLC | $327.79 | 2021-2025 | Wakix |
| Amgen INC. | $232.86 | 2022-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $217.71 | 2019-2023 | Uptravi, Opsumit |
| Mylan Specialty L.P. | $204.35 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $199.60 | 2020-2025 | Aralast, Glassia |
| Sunovion Pharmaceuticals INC. | $193.27 | 2019 | |
| Pulmonx Corporation | $160.32 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Inogen, INC. | $154.20 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $152.96 | 2022-2025 | Smartvest |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $143.08 | 2024-2025 | Brinsupri, Arikayce |
| Genentech USA, INC. | $127.37 | 2019-2023 | Xolair |
| Verona Pharma, INC. | $110.00 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $104.78 | 2025 | Yupelri |
| Philips North America LLC | $95.03 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| United Therapeutics Corporation | $74.26 | 2024-2025 | Tyvaso, Tyvaso |
| Novartis Pharmaceuticals Corporation | $56.76 | 2019-2025 | |
| Circassia INC. | $56.06 | 2019 | |
| Jazz Pharmaceuticals INC. | $52.80 | 2019-2021 | |
| Csl Behring | $51.76 | 2020 | |
| Axsome Therapeutics, INC. | $47.66 | 2023-2024 | Sunosi |
| Merck Sharp & Dohme LLC | $46.80 | 2022-2023 | Keytruda |
| Mallinckrodt Hospital Products INC. | $42.92 | 2020-2022 | |
| Shire North American Group INC | $41.70 | 2019 | |
| Abbvie INC. | $40.59 | 2024 | |
| Advanced Respiratory, INC | $36.26 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $27.14 | 2024 | Lumryz |
| Inspire Medical Systems, INC. | $21.45 | 2024 | Inspire |
| Lilly USA, LLC | $19.51 | 2025 | Zepbound |
| Mallinckrodt Enterprises LLC | $17.77 | 2019 | |
| Zoll Circulation INC | $16.89 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Baxter Healthcare | $16.27 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Allergan, INC. | $16.08 | 2019 | |
| Gilead Sciences, INC. | $15.51 | 2019 | |
| Fisher & Paykel Healthcare INC | $14.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.